Revenues of CITIUS ONCOLOGY, INC. for 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
- Summary
-
CITIUS ONCOLOGY, INC. quarterly Revenues in USD history and change rate for 31 Dec 2025.
- CITIUS ONCOLOGY, INC. Revenues for the quarter ending 31 Dec 2025 was $3,944,111.
- Source SEC data
- View on sec.gov
Revenues, Quarterly (USD)
CITIUS ONCOLOGY, INC. Quarterly Revenues (USD)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $3,944,111 | 01 Oct 2025 | 31 Dec 2025 | 10-Q | 13 Feb 2026 | 2026 | Q1 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.